Helius Medical Technologies Expands Stroke Clinical Program With Participation Of Shepherd Center
Helius Medical Technologies Expands Stroke Clinical Program With Participation Of Shepherd Center
Helius Medical Technologies在謝潑德中心的參與下擴大了中風臨床計劃
-- Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people recovering from stroke ---- Shepherd Center, a top neurorehabilitation hospital, is the third site in Helius' U.S. registrational program for Portable Neuromodulation Stimulator (PoNS) in stroke ---- The single-arm study will evaluate PoNS in treating gait and balance deficits in chronic stroke survivors ---- Regulatory submission seeking marketing authorization for stroke expected in 2025--
— Helius Medical 和 Shepherd Center 合作進行了一項研究，該研究旨在恢復中風患者的行走能力 —— Shepherd Center 是一家頂級神經康復醫院，是 Helius 美國中風便攜式神經調節刺激器 (PonS) 註冊計劃的第三個地點——— 這項單臂研究將評估 PoN 在治療慢性中風倖存者步態和平衡缺陷方面的作用 —--預計將在2025年提交中風上市許可的監管文件--
NEWTOWN, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits...
賓夕法尼亞州紐敦，2024年4月24日（GLOBE NEWSW...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。